Amicogen, Inc. (KOSDAQ:092040)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,865.00
-25.00 (-1.32%)
Apr 29, 2026, 11:50 AM KST
Market Cap133.16B -31.1%
Revenue (ttm)41.98B -75.8%
Net Income-29.96B
EPS-543.00
Shares Out70.45M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume196,217
Average Volume1,061,575
Open1,887.00
Previous Close1,890.00
Day's Range1,840.00 - 1,887.00
52-Week Range1,160.00 - 4,980.00
Beta0.09
RSI53.98
Earnings DateMay 14, 2026

About Amicogen

Amicogen, Inc. operates as an industrial biotechnology company in South Korea and internationally. The company develops, produces, and sells of enzymes and new materials; and produces food-related additives and health functional food. It manufactures and sells of biopharmaceutical materials and resins for purifying pharmaceutical proteins and health and beauty products. In addition, the company offers oral incurable and rare disease treatments, as well as manufactures and sells of pharmaceutical raw materials, animal drugs, human drugs, etc. Th... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 236
Stock Exchange KOSDAQ
Ticker Symbol 092040
Full Company Profile

Financial Performance

In 2025, Amicogen's revenue was 41.98 billion, a decrease of -75.82% compared to the previous year's 173.60 billion. Losses were -29.96 billion, -43.25% less than in 2024.

Financial Statements